Literature DB >> 31001642

Differential miRNA Expression in Ileal and Colonic Tissues Reveals an Altered Immunoregulatory Molecular Profile in Individuals With Crohn's Disease versus Healthy Subjects.

Aylia Mohammadi1, Orlaith B Kelly1,2, Michelle I Smith1, Boyko Kabakchiev1, Mark S Silverberg1,2.   

Abstract

BACKGROUND: MicroRNAs [miRNAs] are key modulators of gene expression in Crohn's disease [CD] and may drive tissue-specific molecular alterations underlying CD susceptibility. In this study, we analysed differential miRNA expression between CD and healthy subjects across ileal and colonic tissues.
METHODS: A cohort of CD and healthy control [HC] subjects was recruited and clinical data collected. Endoscopically quiescent CD [CDq] was defined as inactive or mild by the Simple Endoscopic Score for CD. Total RNA was extracted from endoscopic biopsies taken from the terminal ileum and sigmoid colon. miRNA expression was quantified using NanoString Technologies. Statistical significance was assessed across biopsy site and diagnosis per miRNA, and corrected for multiple testing.
RESULTS: In total, 23 CDq and 38 HC subjects were enrolled; 112 samples were included in the analysis, 51 from the ileum and 61 from the colon. We found 47 miRNAs differentially expressed by biopsy site in healthy tissue. Nine miRNAs were differentially expressed across HC and CDq, accounting for biopsy location. One of these, miR-223-3p, showed age and sex effects. We identified miRNA expression driven by diagnosis targeting genes involved in chemokine and cytokine signalling. miR-31-5p expression was driven by location and may be a biomarker for location subtypes in CD.
CONCLUSIONS: We identified differentially expressed miRNAs in healthy ileal and colonic tissues. We discovered spatial miRNA expression patterns in CD and HC, suggesting site-specific regulation in subjects with no or minimal intestinal inflammation. These miRNAs target genes involved in immunoregulatory processes, suggesting a functional, tissue-specific role in CD.
Copyright © 2019 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Inflammatory bowel disease; immune response; miRNA

Year:  2019        PMID: 31001642      PMCID: PMC6821350          DOI: 10.1093/ecco-jcc/jjz076

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  52 in total

1.  X-chromosome-located microRNAs in immunity: might they explain male/female differences? The X chromosome-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of females.

Authors:  Iris Pinheiro; Lien Dejager; Claude Libert
Journal:  Bioessays       Date:  2011-09-28       Impact factor: 4.345

2.  A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis.

Authors:  Francesco Fazi; Alessandro Rosa; Alessandro Fatica; Vania Gelmetti; Maria Laura De Marchis; Clara Nervi; Irene Bozzoni
Journal:  Cell       Date:  2005-12-02       Impact factor: 41.582

3.  Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease.

Authors:  Feng Wu; Natalie Jia Guo; Hongying Tian; Michael Marohn; Susan Gearhart; Theodore M Bayless; Steven R Brant; John H Kwon
Journal:  Inflamm Bowel Dis       Date:  2010-09-01       Impact factor: 5.325

4.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

Authors:  J Satsangi; M S Silverberg; S Vermeire; J-F Colombel
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

5.  Identification of microRNAs associated with ileal and colonic Crohn's disease.

Authors:  Feng Wu; Simin Zhang; Themistocles Dassopoulos; Mary L Harris; Theodore M Bayless; Stephen J Meltzer; Steven R Brant; John H Kwon
Journal:  Inflamm Bowel Dis       Date:  2010-10       Impact factor: 5.325

6.  MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha.

Authors:  Feng Wu; Michelle Zikusoka; Anil Trindade; Themistocles Dassopoulos; Mary L Harris; Theodore M Bayless; Steven R Brant; Shukti Chakravarti; John H Kwon
Journal:  Gastroenterology       Date:  2008-08-03       Impact factor: 22.682

7.  Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome.

Authors:  Viola Neudecker; Moritz Haneklaus; Owen Jensen; Ludmila Khailova; Joanne C Masterson; Hazel Tye; Kathryn Biette; Paul Jedlicka; Kelley S Brodsky; Mark E Gerich; Matthias Mack; Avril A B Robertson; Matthew A Cooper; Glenn T Furuta; Charles A Dinarello; Luke A O'Neill; Holger K Eltzschig; Seth L Masters; Eóin N McNamee
Journal:  J Exp Med       Date:  2017-05-09       Impact factor: 14.307

8.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Authors:  Luke Jostins; Stephan Ripke; Rinse K Weersma; Richard H Duerr; Dermot P McGovern; Ken Y Hui; James C Lee; L Philip Schumm; Yashoda Sharma; Carl A Anderson; Jonah Essers; Mitja Mitrovic; Kaida Ning; Isabelle Cleynen; Emilie Theatre; Sarah L Spain; Soumya Raychaudhuri; Philippe Goyette; Zhi Wei; Clara Abraham; Jean-Paul Achkar; Tariq Ahmad; Leila Amininejad; Ashwin N Ananthakrishnan; Vibeke Andersen; Jane M Andrews; Leonard Baidoo; Tobias Balschun; Peter A Bampton; Alain Bitton; Gabrielle Boucher; Stephan Brand; Carsten Büning; Ariella Cohain; Sven Cichon; Mauro D'Amato; Dirk De Jong; Kathy L Devaney; Marla Dubinsky; Cathryn Edwards; David Ellinghaus; Lynnette R Ferguson; Denis Franchimont; Karin Fransen; Richard Gearry; Michel Georges; Christian Gieger; Jürgen Glas; Talin Haritunians; Ailsa Hart; Chris Hawkey; Matija Hedl; Xinli Hu; Tom H Karlsen; Limas Kupcinskas; Subra Kugathasan; Anna Latiano; Debby Laukens; Ian C Lawrance; Charlie W Lees; Edouard Louis; Gillian Mahy; John Mansfield; Angharad R Morgan; Craig Mowat; William Newman; Orazio Palmieri; Cyriel Y Ponsioen; Uros Potocnik; Natalie J Prescott; Miguel Regueiro; Jerome I Rotter; Richard K Russell; Jeremy D Sanderson; Miquel Sans; Jack Satsangi; Stefan Schreiber; Lisa A Simms; Jurgita Sventoraityte; Stephan R Targan; Kent D Taylor; Mark Tremelling; Hein W Verspaget; Martine De Vos; Cisca Wijmenga; David C Wilson; Juliane Winkelmann; Ramnik J Xavier; Sebastian Zeissig; Bin Zhang; Clarence K Zhang; Hongyu Zhao; Mark S Silverberg; Vito Annese; Hakon Hakonarson; Steven R Brant; Graham Radford-Smith; Christopher G Mathew; John D Rioux; Eric E Schadt; Mark J Daly; Andre Franke; Miles Parkes; Severine Vermeire; Jeffrey C Barrett; Judy H Cho
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

Review 9.  MicroRNAs in age-related diseases.

Authors:  Stefanie Dimmeler; Pierluigi Nicotera
Journal:  EMBO Mol Med       Date:  2013-01-22       Impact factor: 12.137

Review 10.  Sexual dimorphism of miRNA expression: a new perspective in understanding the sex bias of autoimmune diseases.

Authors:  Rujuan Dai; S Ansar Ahmed
Journal:  Ther Clin Risk Manag       Date:  2014-03-03       Impact factor: 2.423

View more
  11 in total

Review 1.  Putting the "mi" in omics: discovering miRNA biomarkers for pediatric precision care.

Authors:  Chengyin Li; Rhea E Sullivan; Dongxiao Zhu; Steven D Hicks
Journal:  Pediatr Res       Date:  2022-07-29       Impact factor: 3.953

2.  Mucosal microRNAs relate to age and severity of disease in ulcerative colitis.

Authors:  Mikkel Malham; Jaslin P James; Christian Jakobsen; Estrid Hoegdall; Kim Holmstroem; Vibeke Wewer; Boye S Nielsen; Lene B Riis
Journal:  Aging (Albany NY)       Date:  2021-03-01       Impact factor: 5.682

Review 3.  Vitamin D Modulates Intestinal Microbiota in Inflammatory Bowel Diseases.

Authors:  Carolina Battistini; Rafael Ballan; Marcos Edgar Herkenhoff; Susana Marta Isay Saad; Jun Sun
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 5.923

Review 4.  miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis.

Authors:  Jing Zhou; Jialing Liu; Yangyang Gao; Liwei Shen; Sheng Li; Simin Chen
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

Review 5.  Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models.

Authors:  Kanika Suri; Jason A Bubier; Michael V Wiles; Leonard D Shultz; Mansoor M Amiji; Vishnu Hosur
Journal:  Cells       Date:  2021-08-26       Impact factor: 7.666

Review 6.  Differentially Expressed miRNAs in Ulcerative Colitis and Crohn's Disease.

Authors:  Reza Yarani; Ali Shojaeian; Oana Palasca; Nadezhda T Doncheva; Lars Juhl Jensen; Jan Gorodkin; Flemming Pociot
Journal:  Front Immunol       Date:  2022-06-06       Impact factor: 8.786

Review 7.  Adherent-Invasive E. coli: Update on the Lifestyle of a Troublemaker in Crohn's Disease.

Authors:  Mélissa Chervy; Nicolas Barnich; Jérémy Denizot
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

Review 8.  MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer.

Authors:  Jaslin P James; Lene Buhl Riis; Mikkel Malham; Estrid Høgdall; Ebbe Langholz; Boye S Nielsen
Journal:  Int J Mol Sci       Date:  2020-10-24       Impact factor: 5.923

9.  Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications.

Authors:  Inés Moret-Tatay; Elena Cerrillo; David Hervás; Marisa Iborra; Esteban Sáez-González; Javier Forment; Luis Tortosa; Pilar Nos; Jose Gadea; Belén Beltrán
Journal:  Clin Transl Gastroenterol       Date:  2021-10-25       Impact factor: 4.488

10.  Profiling non-coding RNA levels with clinical classifiers in pediatric Crohn's disease.

Authors:  Ranjit Pelia; Suresh Venkateswaran; Jason D Matthews; Yael Haberman; David J Cutler; Jeffrey S Hyams; Lee A Denson; Subra Kugathasan
Journal:  BMC Med Genomics       Date:  2021-07-29       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.